OPINION: ETF analysts Eric Balchunas and James Seyffart predict that MicroStrategy will join the Nasdaq 100 by December 23, potentially replacing Moderna, due to its significant Bitcoin investments.
Disclaimer: Includes third-party opinions. No financial advice. May include sponsored content.See T&Cs.
